世界のヒトマイクロバイオーム治療薬市場

QYResearchが発行した調査報告書(QYR802A2631)
◆英語タイトル:Global Human Microbiome Therapeutics Market Research Report 2017
◆商品コード:QYR802A2631
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年1月
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、ヒトマイクロバイオーム治療薬のグローバル市場について調査・分析し、ヒトマイクロバイオーム治療薬の世界市場概観、ヒトマイクロバイオーム治療薬の種類別市場分析、用途別市場分析、ヒトマイクロバイオーム治療薬の世界市場規模予測、関連企業分析、主要地域別分析(アメリカ市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・ヒトマイクロバイオーム治療薬の世界市場概観
・ヒトマイクロバイオーム治療薬の種類別市場規模
・ヒトマイクロバイオーム治療薬の用途別市場規模
・ヒトマイクロバイオーム治療薬の世界市場規模
・ヒトマイクロバイオーム治療薬の世界市場規模予測
・ヒトマイクロバイオーム治療薬の主要地域別市場規模
・ヒトマイクロバイオーム治療薬のアメリカ市場規模・予測
・ヒトマイクロバイオーム治療薬のヨーロッパ市場規模・予測
・ヒトマイクロバイオーム治療薬の中国市場規模・予測
・ヒトマイクロバイオーム治療薬の日本市場規模・予測
・ヒトマイクロバイオーム治療薬のアジア市場規模・予測
・ヒトマイクロバイオーム治療薬の製造メーカー分析
・ヒトマイクロバイオーム治療薬のメーカー別生産量
・ヒトマイクロバイオーム治療薬のメーカー別市場シェア
・ヒトマイクロバイオーム治療薬の価格動向・価格分析
・ヒトマイクロバイオーム治療薬の販売(売上高)動向
・ヒトマイクロバイオーム治療薬の貿易(輸出・輸入)動向
・ヒトマイクロバイオーム治療薬の産業チェーン分析
・ヒトマイクロバイオーム治療薬のマーケティング戦略分析
・ヒトマイクロバイオーム治療薬の販売業者(代理店)リスト
・ヒトマイクロバイオーム治療薬の市場環境分析
...
【レポートの概要】

In this report, the global Human Microbiome Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Microbiome Therapeutics in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Human Microbiome Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
ENTEROME Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Upper GIT
Lower GIT
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Intestines And Stomach
Oral
Respiratory Tract
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Human Microbiome Therapeutics Market Research Report 2017
1 Human Microbiome Therapeutics Market Overview
1.1 Product Overview and Scope of Human Microbiome Therapeutics
1.2 Human Microbiome Therapeutics Segment by Type (Product Category)
1.2.1 Global Human Microbiome Therapeutics Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Human Microbiome Therapeutics Production Market Share by Type (Product Category) in 2016
1.2.3 Upper GIT
1.2.4 Lower GIT
1.3 Global Human Microbiome Therapeutics Segment by Application
1.3.1 Human Microbiome Therapeutics Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Intestines And Stomach
1.3.3 Oral
1.3.4 Respiratory Tract
1.3.5 Other
1.4 Global Human Microbiome Therapeutics Market by Region (2012-2022)
1.4.1 Global Human Microbiome Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Human Microbiome Therapeutics (2012-2022)
1.5.1 Global Human Microbiome Therapeutics Revenue Status and Outlook (2012-2022)
1.5.2 Global Human Microbiome Therapeutics Capacity, Production Status and Outlook (2012-2022)

2 Global Human Microbiome Therapeutics Market Competition by Manufacturers
2.1 Global Human Microbiome Therapeutics Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Human Microbiome Therapeutics Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Human Microbiome Therapeutics Production and Share by Manufacturers (2012-2017)
2.2 Global Human Microbiome Therapeutics Revenue and Share by Manufacturers (2012-2017)
2.3 Global Human Microbiome Therapeutics Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Human Microbiome Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Human Microbiome Therapeutics Market Competitive Situation and Trends
2.5.1 Human Microbiome Therapeutics Market Concentration Rate
2.5.2 Human Microbiome Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Human Microbiome Therapeutics Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Human Microbiome Therapeutics Capacity and Market Share by Region (2012-2017)
3.2 Global Human Microbiome Therapeutics Production and Market Share by Region (2012-2017)
3.3 Global Human Microbiome Therapeutics Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Human Microbiome Therapeutics Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Human Microbiome Therapeutics Consumption by Region (2012-2017)
4.2 North America Human Microbiome Therapeutics Production, Consumption, Export, Import (2012-2017)
4.3 Europe Human Microbiome Therapeutics Production, Consumption, Export, Import (2012-2017)
4.4 China Human Microbiome Therapeutics Production, Consumption, Export, Import (2012-2017)
4.5 Japan Human Microbiome Therapeutics Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Human Microbiome Therapeutics Production, Consumption, Export, Import (2012-2017)
4.7 India Human Microbiome Therapeutics Production, Consumption, Export, Import (2012-2017)

5 Global Human Microbiome Therapeutics Production, Revenue (Value), Price Trend by Type
5.1 Global Human Microbiome Therapeutics Production and Market Share by Type (2012-2017)
5.2 Global Human Microbiome Therapeutics Revenue and Market Share by Type (2012-2017)
5.3 Global Human Microbiome Therapeutics Price by Type (2012-2017)
5.4 Global Human Microbiome Therapeutics Production Growth by Type (2012-2017)

6 Global Human Microbiome Therapeutics Market Analysis by Application
6.1 Global Human Microbiome Therapeutics Consumption and Market Share by Application (2012-2017)
6.2 Global Human Microbiome Therapeutics Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Human Microbiome Therapeutics Manufacturers Profiles/Analysis
7.1 ENTEROME Bioscience
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Human Microbiome Therapeutics Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 ENTEROME Bioscience Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Rebiotix
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Human Microbiome Therapeutics Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Rebiotix Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Seres Therapeutics
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Human Microbiome Therapeutics Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Seres Therapeutics Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Vedanta Biosciences
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Human Microbiome Therapeutics Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Vedanta Biosciences Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Bristol-Myers Squibb
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Human Microbiome Therapeutics Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Johnson & Johnson
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Human Microbiome Therapeutics Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Johnson & Johnson Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Takeda Pharmaceutical
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Human Microbiome Therapeutics Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview

8 Human Microbiome Therapeutics Manufacturing Cost Analysis
8.1 Human Microbiome Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Human Microbiome Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Human Microbiome Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Human Microbiome Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Human Microbiome Therapeutics Market Forecast (2017-2022)
12.1 Global Human Microbiome Therapeutics Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Human Microbiome Therapeutics Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Human Microbiome Therapeutics Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Human Microbiome Therapeutics Price and Trend Forecast (2017-2022)
12.2 Global Human Microbiome Therapeutics Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Human Microbiome Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Human Microbiome Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Human Microbiome Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Human Microbiome Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Human Microbiome Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Human Microbiome Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Human Microbiome Therapeutics Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Human Microbiome Therapeutics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Tables and Figures

Figure Picture of Human Microbiome Therapeutics
Figure Global Human Microbiome Therapeutics Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Human Microbiome Therapeutics Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Upper GIT
Table Major Manufacturers of Upper GIT
Figure Product Picture of Lower GIT
Table Major Manufacturers of Lower GIT
Figure Global Human Microbiome Therapeutics Consumption (K Units) by Applications (2012-2022)
Figure Global Human Microbiome Therapeutics Consumption Market Share by Applications in 2016
Figure Intestines And Stomach Examples
Table Key Downstream Customer in Intestines And Stomach
Figure Oral Examples
Table Key Downstream Customer in Oral
Figure Respiratory Tract Examples
Table Key Downstream Customer in Respiratory Tract
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Human Microbiome Therapeutics Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Human Microbiome Therapeutics Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Human Microbiome Therapeutics Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Human Microbiome Therapeutics Major Players Product Capacity (K Units) (2012-2017)
Table Global Human Microbiome Therapeutics Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Human Microbiome Therapeutics Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Human Microbiome Therapeutics Capacity (K Units) of Key Manufacturers in 2016
Figure Global Human Microbiome Therapeutics Capacity (K Units) of Key Manufacturers in 2017
Figure Global Human Microbiome Therapeutics Major Players Product Production (K Units) (2012-2017)
Table Global Human Microbiome Therapeutics Production (K Units) of Key Manufacturers (2012-2017)
Table Global Human Microbiome Therapeutics Production Share by Manufacturers (2012-2017)
Figure 2016 Human Microbiome Therapeutics Production Share by Manufacturers
Figure 2017 Human Microbiome Therapeutics Production Share by Manufacturers
Figure Global Human Microbiome Therapeutics Major Players Product Revenue (Million USD) (2012-2017)
Table Global Human Microbiome Therapeutics Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Human Microbiome Therapeutics Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Human Microbiome Therapeutics Revenue Share by Manufacturers
Table 2017 Global Human Microbiome Therapeutics Revenue Share by Manufacturers
Table Global Market Human Microbiome Therapeutics Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Human Microbiome Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Human Microbiome Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Human Microbiome Therapeutics Product Category
Figure Human Microbiome Therapeutics Market Share of Top 3 Manufacturers
Figure Human Microbiome Therapeutics Market Share of Top 5 Manufacturers
Table Global Human Microbiome Therapeutics Capacity (K Units) by Region (2012-2017)
Figure Global Human Microbiome Therapeutics Capacity Market Share by Region (2012-2017)
Figure Global Human Microbiome Therapeutics Capacity Market Share by Region (2012-2017)
Figure 2016 Global Human Microbiome Therapeutics Capacity Market Share by Region
Table Global Human Microbiome Therapeutics Production by Region (2012-2017)
Figure Global Human Microbiome Therapeutics Production (K Units) by Region (2012-2017)
Figure Global Human Microbiome Therapeutics Production Market Share by Region (2012-2017)
Figure 2016 Global Human Microbiome Therapeutics Production Market Share by Region
Table Global Human Microbiome Therapeutics Revenue (Million USD) by Region (2012-2017)
Table Global Human Microbiome Therapeutics Revenue Market Share by Region (2012-2017)
Figure Global Human Microbiome Therapeutics Revenue Market Share by Region (2012-2017)
Table 2016 Global Human Microbiome Therapeutics Revenue Market Share by Region
Figure Global Human Microbiome Therapeutics Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Human Microbiome Therapeutics Consumption (K Units) Market by Region (2012-2017)
Table Global Human Microbiome Therapeutics Consumption Market Share by Region (2012-2017)
Figure Global Human Microbiome Therapeutics Consumption Market Share by Region (2012-2017)
Figure 2016 Global Human Microbiome Therapeutics Consumption (K Units) Market Share by Region
Table North America Human Microbiome Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Human Microbiome Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Human Microbiome Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Human Microbiome Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Human Microbiome Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Human Microbiome Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Human Microbiome Therapeutics Production (K Units) by Type (2012-2017)
Table Global Human Microbiome Therapeutics Production Share by Type (2012-2017)
Figure Production Market Share of Human Microbiome Therapeutics by Type (2012-2017)
Figure 2016 Production Market Share of Human Microbiome Therapeutics by Type
Table Global Human Microbiome Therapeutics Revenue (Million USD) by Type (2012-2017)
Table Global Human Microbiome Therapeutics Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Human Microbiome Therapeutics by Type (2012-2017)
Figure 2016 Revenue Market Share of Human Microbiome Therapeutics by Type
Table Global Human Microbiome Therapeutics Price (USD/Unit) by Type (2012-2017)
Figure Global Human Microbiome Therapeutics Production Growth by Type (2012-2017)
Table Global Human Microbiome Therapeutics Consumption (K Units) by Application (2012-2017)
Table Global Human Microbiome Therapeutics Consumption Market Share by Application (2012-2017)
Figure Global Human Microbiome Therapeutics Consumption Market Share by Applications (2012-2017)
Figure Global Human Microbiome Therapeutics Consumption Market Share by Application in 2016
Table Global Human Microbiome Therapeutics Consumption Growth Rate by Application (2012-2017)
Figure Global Human Microbiome Therapeutics Consumption Growth Rate by Application (2012-2017)
Table ENTEROME Bioscience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ENTEROME Bioscience Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ENTEROME Bioscience Human Microbiome Therapeutics Production Growth Rate (2012-2017)
Figure ENTEROME Bioscience Human Microbiome Therapeutics Production Market Share (2012-2017)
Figure ENTEROME Bioscience Human Microbiome Therapeutics Revenue Market Share (2012-2017)
Table Rebiotix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rebiotix Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Rebiotix Human Microbiome Therapeutics Production Growth Rate (2012-2017)
Figure Rebiotix Human Microbiome Therapeutics Production Market Share (2012-2017)
Figure Rebiotix Human Microbiome Therapeutics Revenue Market Share (2012-2017)
Table Seres Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seres Therapeutics Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seres Therapeutics Human Microbiome Therapeutics Production Growth Rate (2012-2017)
Figure Seres Therapeutics Human Microbiome Therapeutics Production Market Share (2012-2017)
Figure Seres Therapeutics Human Microbiome Therapeutics Revenue Market Share (2012-2017)
Table Vedanta Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vedanta Biosciences Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vedanta Biosciences Human Microbiome Therapeutics Production Growth Rate (2012-2017)
Figure Vedanta Biosciences Human Microbiome Therapeutics Production Market Share (2012-2017)
Figure Vedanta Biosciences Human Microbiome Therapeutics Revenue Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Human Microbiome Therapeutics Production Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Human Microbiome Therapeutics Production Market Share (2012-2017)
Figure Bristol-Myers Squibb Human Microbiome Therapeutics Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Human Microbiome Therapeutics Production Growth Rate (2012-2017)
Figure Johnson & Johnson Human Microbiome Therapeutics Production Market Share (2012-2017)
Figure Johnson & Johnson Human Microbiome Therapeutics Revenue Market Share (2012-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Human Microbiome Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Human Microbiome Therapeutics Production Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Human Microbiome Therapeutics Production Market Share (2012-2017)
Figure Takeda Pharmaceutical Human Microbiome Therapeutics Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Microbiome Therapeutics
Figure Manufacturing Process Analysis of Human Microbiome Therapeutics
Figure Human Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Human Microbiome Therapeutics Major Manufacturers in 2016
Table Major Buyers of Human Microbiome Therapeutics
Table Distributors/Traders List
Figure Global Human Microbiome Therapeutics Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Human Microbiome Therapeutics Price (Million USD) and Trend Forecast (2017-2022)
Table Global Human Microbiome Therapeutics Production (K Units) Forecast by Region (2017-2022)
Figure Global Human Microbiome Therapeutics Production Market Share Forecast by Region (2017-2022)
Table Global Human Microbiome Therapeutics Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Human Microbiome Therapeutics Consumption Market Share Forecast by Region (2017-2022)
Figure North America Human Microbiome Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Human Microbiome Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Human Microbiome Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Human Microbiome Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Human Microbiome Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Human Microbiome Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Human Microbiome Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Human Microbiome Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Human Microbiome Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Human Microbiome Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Human Microbiome Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Human Microbiome Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Human Microbiome Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Human Microbiome Therapeutics Production (K Units) Forecast by Type (2017-2022)
Figure Global Human Microbiome Therapeutics Production (K Units) Forecast by Type (2017-2022)
Table Global Human Microbiome Therapeutics Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Human Microbiome Therapeutics Revenue Market Share Forecast by Type (2017-2022)
Table Global Human Microbiome Therapeutics Price Forecast by Type (2017-2022)
Table Global Human Microbiome Therapeutics Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Human Microbiome Therapeutics Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のヒトマイクロバイオーム治療薬市場(Global Human Microbiome Therapeutics Market Research Report 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆